

XOMA is at the forefront of antibody discovery and development, one of the most powerful and transformative fields of drug innovation Among its major competitors, XOMA is ranked in 6th place for NPS while Roche is 1st, and GlaxoSmithKline is 2nd.Their current market cap is $200.68M